Literature DB >> 921746

Specificity of interactions of hapten side chains with the combining site of the myeloma protein MOPC 315.

S Wain-Hobson, S K Dower, P Gettins, D Givol, A C McLaughlin, I Pecht, C A Sunderland, R A Dwek.   

Abstract

The pKa values of the three histidine residues in the Fv fragment (variable region of the heavy and light chains) of the mouse myeloma protein MOPC 315, measured by high resolution n.m.r. (nuclear magnetic resonance), are 5.9, 6.9 and 8.2. The perturbation of the pKa of one of the histidines (pKa 6.9) on the addition of hapten and the narrow linewidth of its proton resonances suggests that it is at the edge of the combining site. References to the model of the Fv fragment [Padlan, Davies, Pecht, Givol & Wright (1976) Cold Spring Harbor Symp. Quant. Biol. 41, in the press] allows assignment of the three histidine residues, histidine-102H, histidine-97L and histidine-44L. The determination of the pKa of the phosphorus group, by 31P n.m.r., of a homologous series of Dnp- and Tnp- (di- and tri-nitrophenyl) haptens has located a positively charged residue. Molecular-model studies on the conformations of these haptens show that the residue is at the edge of the site. The model suggests that the positively charged residue is either arginine-95L or lysine-52H.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 921746      PMCID: PMC1164893          DOI: 10.1042/bj1650227

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  The gross architecture of an antibody-combining site as determined by spin-label mapping.

Authors:  B J Sutton; P Gettins; D Givol; D Marsh; S Wain-Hobson; K J Willan; R A Dwek
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

2.  Antibody--hapten interactions in solution.

Authors:  R A Dwek; R Jones; D Marsh; A C McLaughlin; E M Press; N C Price; A I White
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1975-11-06       Impact factor: 6.237

3.  Localization of antibody-combining sites within the variable portions of heavy and light chains.

Authors:  D Inbar; J Hochman; D Givol
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

4.  Kinetic mapping of the antibody combining site by chemical relaxation spectrometry.

Authors:  D Haselkorn; S Friedman; D Givol; I Pecht
Journal:  Biochemistry       Date:  1974-05-07       Impact factor: 3.162

5.  Mathematical models for interacting groups in nuclear magnetic resonance titration curves.

Authors:  R I Shrager; J S Cohen; S R Heller; D H Sachs; A N Schechter
Journal:  Biochemistry       Date:  1972-02-15       Impact factor: 3.162

6.  Arginine as a contact residue in the hapten-binding site of protein 315.

Authors:  J Klostergaard; L M Krausz; A L Grossberg; D Pressman
Journal:  Immunochemistry       Date:  1977-02

7.  Absence of lysine from the DNP-lysine binding site of protein 315; designation of lysine 52 of the heavy chain as a peripheral residue.

Authors:  J Klostergaard; A L Grossberg; L M Krausz; D Pressman
Journal:  Immunochemistry       Date:  1977-01

8.  Structure-function relationships in lactate dehydrogenase.

Authors:  M J Adams; M Buehner; K Chandrasekhar; G C Ford; M L Hackert; A Liljas; M G Rossmann; I E Smiley; W S Allison; J Everse; N O Kaplan; S S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

9.  Affinity labeling of a mouse myeloma protein which binds nitrophenyl ligands. Sequence and position of a labeled tryptic peptide.

Authors:  E J Goetzl; H Metzger
Journal:  Biochemistry       Date:  1970-09-29       Impact factor: 3.162

10.  The combining site of the dinitrophenyl-binding immunoglobulin A myeloma protein MOPC 315.

Authors:  S K Dower; S Wain-Hobson; P Gettins; D Givol; W R Jackson; S J Perkins; C A Sunderland; B J Sutton; C E Wright; R A Dwek
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

View more
  4 in total

1.  The gross architecture of an antibody-combining site as determined by spin-label mapping.

Authors:  B J Sutton; P Gettins; D Givol; D Marsh; S Wain-Hobson; K J Willan; R A Dwek
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

2.  The combining site of the dinitrophenyl-binding immunoglobulin A myeloma protein MOPC 315.

Authors:  S K Dower; S Wain-Hobson; P Gettins; D Givol; W R Jackson; S J Perkins; C A Sunderland; B J Sutton; C E Wright; R A Dwek
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

3.  The binding of 2,4,6-trinitrophenyl derivatives to the mouse myeloma immunoglobulin A protein MOPC 315.

Authors:  S K Dower; P Gettins; R Jackson; R A Dwek; D Givol
Journal:  Biochem J       Date:  1978-01-01       Impact factor: 3.857

4.  The variability of nitro group--protein interaction in the 2,4-dinitrophenyl-binding antibodies M315, M460 and X25 investigated by resonance Raman spectroscopy.

Authors:  P Gettins; R A Dwek; R N Perutz
Journal:  Biochem J       Date:  1981-07-01       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.